Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Kubota

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Gut and Liver|July 15, 2025
Can Dual Delayed-Release Esomeprazole Replace Dexlansoprazole?Dai Kubota, Yosuke Tsuji, Mitsuhiro Fujishiro
Clinical Journal of Gastroenterology|November 12, 2024
A ring-shaped gas sign: a case of the accidental ingestion of a press-through packageDai Kubota, Yosuke Tsuji, Yoku Hayakawa, et al.
Gastrointestinal Endoscopy|August 2, 2022
An unexpected adverse event of endoscopic ultrasonography: acute aortic dissectionDai Kubota, Yosuke Tsuji, Hiroya Mizutani, et al.
Endoscopy|December 21, 2021
Subtotal esophageal endoscopic submucosal dissection for long-segment Barrett's esophagus and adenocarcinomaDai Kubota, Yoshiki Sakaguchi, Sayaka Nagao, et al.
Bioorganic & Medicinal Chemistry|November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activityDai Kubota, Minoru Ishikawa, Mikio Yamamoto, et al.
Bioorganic & Medicinal Chemistry|November 26, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubilityMinoru Ishikawa, Yukiko Hiraiwa, Dai Kubota, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitutionDai Kubota, Minoru Ishikawa, Midori Ishikawa, et al.
Bioorganic & Medicinal Chemistry|November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonistsMinoru Ishikawa, Dai Kubota, Mikio Yamamoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|August 17, 2025
Impact of Glucagon-Like Peptide-1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score-Matched StudyHiroyuki Hisada, Yosuke Tsuji, Dai Kubota, et al.
Surgical Endoscopy|January 9, 2023
Risk factors for incomplete resection with pharyngeal endoscopic submucosal dissection and long-term prognosis after resectionYoshiki Sakaguchi, Yuki Saito, Mizuo Ando, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Gut and Liver|July 15, 2025
Can Dual Delayed-Release Esomeprazole Replace Dexlansoprazole?Dai Kubota, Yosuke Tsuji, Mitsuhiro Fujishiro
Clinical Journal of Gastroenterology|November 12, 2024
A ring-shaped gas sign: a case of the accidental ingestion of a press-through packageDai Kubota, Yosuke Tsuji, Yoku Hayakawa, et al.
Gastrointestinal Endoscopy|August 2, 2022
An unexpected adverse event of endoscopic ultrasonography: acute aortic dissectionDai Kubota, Yosuke Tsuji, Hiroya Mizutani, et al.
Endoscopy|December 21, 2021
Subtotal esophageal endoscopic submucosal dissection for long-segment Barrett's esophagus and adenocarcinomaDai Kubota, Yoshiki Sakaguchi, Sayaka Nagao, et al.
Bioorganic & Medicinal Chemistry|November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activityDai Kubota, Minoru Ishikawa, Mikio Yamamoto, et al.
Bioorganic & Medicinal Chemistry|November 26, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubilityMinoru Ishikawa, Yukiko Hiraiwa, Dai Kubota, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitutionDai Kubota, Minoru Ishikawa, Midori Ishikawa, et al.
Bioorganic & Medicinal Chemistry|November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonistsMinoru Ishikawa, Dai Kubota, Mikio Yamamoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|August 17, 2025
Impact of Glucagon-Like Peptide-1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score-Matched StudyHiroyuki Hisada, Yosuke Tsuji, Dai Kubota, et al.
Surgical Endoscopy|January 9, 2023
Risk factors for incomplete resection with pharyngeal endoscopic submucosal dissection and long-term prognosis after resectionYoshiki Sakaguchi, Yuki Saito, Mizuo Ando, et al.
Pageof 3